Biotech executive and scientist focused on translating molecular discoveries into scalable, high-impact biotechnological solutions. My work integrates bioinformatics, omics technologies, and bioprocessing to accelerate the development of bioproducts. I lead the analytical development of monoclonal antibodies for cancer, applying advanced molecular biology techniques within robust quality frameworks to ensure translational value. Currently pursuing a Master in Business Management, strategically integrating scientific expertise with business acumen to drive impactful innovation in biotechnology and life sciences. 🧬 Key expertise: * Omics-driven discovery & product development * Cell culture & upstream bioprocessing * Process innovation & leadership * Molecular biology & advanced analytical techniques